Cancer BiologybioRxivPreprint
Mutant KRAS dosage contributes to heterogeneity in lung cancer therapeutic response
Alice T. Browne, Chris McCann, William J. McDaid…·Emma M. Kerr
This study shows that mutant KRAS dosage affects therapeutic response in lung cancer, with higher dosages linked to resistance to platinum therapy and sensitivity to pS6K inhibition.
DOI 10.64898/2026.05.06.723208